PharmaVOICE - 
January 2005
Purchase Issue

In Every Issue
PharmaOutlet
To Err is Human How Personal Health Records Can help It [...]
By
For Art’s Sake
Creative Review Each month, this department pays homage to memorable [...]
By
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia [...]
By
Talent Pool
talent pool executive appointments and promotions in the healthcare industry [...]
By
E-Media
E-Media New Electronic and Web-based Applications, Sites, and Technologies Wolters [...]
By
What’s New
What’s New New healthcare-related products, services, and companies Corbett Accel [...]
By
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare [...]
By
Letter from the Editor
Letter From The Editor Defining Leadership According to noted author [...]
By

Taren Grom, Editor

Raise Your Voice — Letters
Medicare Part D: It’s “Crunch Time” and Many Brand Teams [...]
By

On The Cover

Born in the U.S.A.?
January 2005 PharmaVOICE 6 Born in the U.S.A.? By Elisabeth Pena Pharmaceutical companies have found success in the offshoring of manufacturing, IT, data management, and clinical-trial operations. will discovery be next to be shipped overseas? Drug discovery symbolizes the birth of a pharmaceutical product and is the first step in its development. Drug discovery also [...]
By

Elisabeth Pena

Features

Simon Best — Striking the Right Chords for Success
Striking the Right Chords for SUCCESS The one-time tour manager of a successful British pop band has adapted his leadership skills to some highly taxing and complex areas, such as cloning and genetic modification. Simon Best is taking the lessons he has learned in the music business and the life-sciences industry to turn Ardana Bioscience [...]
By

Kim Ribbink

Developing a CDISC Intelligence Quotient
Developing a CDISC Intelligence Quotient Some CDISC members envision a time in the future when at least three of the CDISC standards will be combined into one. Until then, the question remains: what does CDISC-compliant mean to you? By breaking down the components of CDISC, people can better understand what it really means to comply [...]
By
E-Submissions: On the Brink of Going Paperless
E-submissions On the Brink of Going Paperless By Denise Myshko The shift from static paper regulatory applications to dynamic and interactive electronic submissions will make data more accessible to reviewers and, ultimately, improve the efficiency of the review process. December 15, 2004, was a day unlike any other at Wyeth Pharmaceuticals. That Wednesday, the company [...]
By

Denise Myshko

CNS: A Complex Therapeutic and Patient-Recruitment Market
CNS By Lisa Dress A Complex Therapeutic and Patient-Recruitment Market An explosion of new science is leading to potential compounds to treat CNS diseases. The challenge for pharmaceutical companies and their partners is recruiting and retaining patients for trials. Understanding the brain and how it functions has been one of the great, unanswered questions in [...]
By

Lisa Dress

2nd Chances
2nd Chances By Elisabeth Pena For products that are not performing to expectations, a relaunch can revitalize a stale brand, highlight new clinical evidence, or give a product another chance to reach the patients it was designed to treat. With each therapy that a pharma company produces, the goal is to create and own a [...]
By

Elisabeth Pena

Obesity: A Market in Need of a Solution
Obesity A Market in Need of a Solution By Denise Myshko with a potentially open market for drugs to treat obesity and related diseases, pharmaceutical companies not only have to provide a pharmacological solution but also address the life-style issues associated with the disease and develop safe products that are effective and have few side [...]
By

Denise Myshko

FEEDBACK